Tech Company Financing Transactions

Cardiac Dimensions Funding Round

Cardiac Dimensions closed a $35 million Series D funding round on 1/6/2023. Investors included Horizon 3, Arboretum Ventures and EQT Life Sciences.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series D
Proceeds Purpose
The company intends to use the funds to enroll the U.S. EMPOWER pivotal study of the Carillon therapy, which commenced late last summer and includes leading centers such as the Cleveland Clinic, Columbia University Medical Center, and Ronald Reagan UCLA Medical Center, and expand sales of the Carillon device in several European countries where it has full reimbursement.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
5540 Lake Washington Blvd. Northeast
Kirkland, WA 98033
Email Address
The CARILLON Mitral Contour System is a groundbreaking, non-surgical device developed to treat functional mitral regurgitation.
Cardiac Dimensions LinkedIn Company Profile
Social Media
Cardiac Dimensions Company Twitter Account
Company News
Cardiac Dimensions News
Cardiac Dimensions on Facebook
Cardiac Dimensions on YouTube

Management Team

Email & Social
Chief Executive Officer
Rick Wypych
  Rick Wypych LinkedIn Profile  Rick Wypych Twitter Account  Rick Wypych News  Rick Wypych on Facebook
Chief Medical Officer
Steven Goldberg
  Steven Goldberg LinkedIn Profile  Steven Goldberg Twitter Account  Steven Goldberg News  Steven Goldberg on Facebook
Vice President
Gretchen Gary
  Gretchen Gary LinkedIn Profile  Gretchen Gary Twitter Account  Gretchen Gary News  Gretchen Gary on Facebook
VP - Operations
Bob Calcote
  Bob Calcote LinkedIn Profile  Bob Calcote Twitter Account  Bob Calcote News  Bob Calcote on Facebook
VP - Regulatory Affairs
Matthew Stark
  Matthew Stark LinkedIn Profile  Matthew Stark Twitter Account  Matthew Stark News  Matthew Stark on Facebook
VP - Sales
Carmelo Mastrandrea
  Carmelo Mastrandrea LinkedIn Profile  Carmelo Mastrandrea Twitter Account  Carmelo Mastrandrea News  Carmelo Mastrandrea on Facebook



Browse more venture capital transactions:

Prev: 1/6/2023: KeyCare venture capital transaction
Next: 1/6/2023: BioVersys venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are derived from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary